EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 340 filers reported holding EXELIXIS INC in Q2 2021. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $285,208 | +1.9% | 13,053 | -1.3% | 0.03% | -38.8% |
| Q3 2021 | $280,000 | +51.4% | 13,229 | +30.2% | 0.05% | +36.1% |
| Q2 2021 | $185,000 | -19.2% | 10,158 | 0.0% | 0.04% | -23.4% |
| Q1 2021 | $229,000 | +14.5% | 10,158 | +1.9% | 0.05% | 0.0% |
| Q4 2020 | $200,000 | -11.5% | 9,969 | +7.7% | 0.05% | -26.6% |
| Q3 2020 | $226,000 | -3.4% | 9,260 | -6.2% | 0.06% | -5.9% |
| Q2 2020 | $234,000 | -13.3% | 9,872 | -37.0% | 0.07% | -30.6% |
| Q1 2020 | $270,000 | +10.7% | 15,663 | +13.3% | 0.10% | +27.3% |
| Q4 2019 | $244,000 | – | 13,823 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
| Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
| CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
| SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
| Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
| Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
| Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
| Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.93% |